News & Updates

Taiwan Semiconductor Manufacturing, often known as TSMC, is the world's biggest contract semiconductor, handling more than 50% of contract chip production in the world, and an estimated 90% of contract production for advanced chips. TSMC is now one of the most valuable companies in the world, and it's the company that tech titans like Apple, Nvidia, Broadcom, Advanced Micro Devices, and Qualcomm, among others, making it a linchpin in the global technology supply chain. TSMC has delivered impressive growth through the AI era, and the company benefits from significant competitive advantages in capacity, expertise, technology, and customer relationships.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption (IDE) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. The prospective, multi-center, single-arm IDE study included 137 patients who underwent urologic procedures using the Hugo™ robotic-assisted surgery (RAS) system.

Despite a ton of volatility, shares of Dutch Bros (NYSE: BROS) are still up 98% in the past 12 months (as of April 22). It's dominated by incumbent Starbucks (NASDAQ: SBUX). Investors looking to put capital to work in the retail coffee industry are looking at Dutch Bros and Starbucks.

Amazon, Apple, Meta, and Microsoft will need to address tariffs on earnings calls next week. Tech executives are sounding alarms.

We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to take a look at where Bitdeer Technologies Group (NASDAQ:BTDR) stands against other firms that recorded double-digit gains last week. Ten companies finished the past trading week on a high note, outperforming the three […]

We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to take a look at where SoundHound AI Inc. (NASDAQ:SOUN) stands against other firms that recorded double-digit gains last week. Ten companies finished the past trading week on a high note, outperforming the three […]

We recently published a list of Why These 10 Firms Recorded Double-Digit Gains Last Week. In this article, we are going to take a look at where Reddit Inc. (NYSE:RDDT) stands against other firms that recorded double-digit gains last week. Ten companies finished the past trading week on a high note, outperforming the three major […]

Johnson & Johnson (NYSE: JNJ) today announced first results from Cohort 4 of the Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with certain types of bladder cancer. These first results show the promise of TAR-200 in this patient population with more than an 80 percent disease-free survival (DFS) rate without the need for reinduction and 94 percent of patients able to preserve their bladder. The high DFS and bladder preservation rate combine

Johnson & Johnson (NYSE: JNJ) today announced new data from Cohort 2 of the pivotal Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with certain types of bladder cancer. The findings demonstrate the highest complete response rate without reinduction with more than half of responders remaining cancer-free for at least 12 months. These results highlight the potential of TAR-200 as a breakthrough for people with Bacillus Calmette-Guérin (BCG)-un

Cathie Wood has been looking for bargains.